Search hospitals > Michigan > Dearborn
Beaumont Hospital - Dearborn
Claim this profileDearborn, Michigan 48124
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Recurrence
Conducts research for Lung Cancer
Conducts research for Ovarian Cancer
237 reported clinical trials
24 medical researchers
Summary
Beaumont Hospital - Dearborn is a medical facility located in Dearborn, Michigan. This center is recognized for care of Cancer, Breast Cancer, Recurrence, Lung Cancer, Ovarian Cancer and other specialties. Beaumont Hospital - Dearborn is involved with conducting 237 clinical trials across 405 conditions. There are 24 research doctors associated with this hospital, such as Tareq Al Baghdadi, Laura K. Gowans, Philip J. Stella, and Samir Narayan.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Breast Cancer
Global LeaderER positive
HER2 negative
Stage IV
Top PIs
Tareq Al BaghdadiSaint Joseph Mercy Hospital7 years of reported clinical research
Expert in Cancer
Expert in Tumors
70 reported clinical trials
127 drugs studied
Laura K. GowansBeaumont Children's Hospital-Royal Oak4 years of reported clinical research
Expert in Tumors
Expert in Brain Tumor
40 reported clinical trials
92 drugs studied
Philip J. StellaSaint Joseph Mercy Hospital4 years of reported clinical research
Expert in Lung Cancer
Expert in Non-Small Cell Lung Cancer
38 reported clinical trials
89 drugs studied
Samir NarayanSaint Joseph Mercy Hospital2 years of reported clinical research
Expert in Cancer
Studies Prostate Cancer
26 reported clinical trials
70 drugs studied
Clinical Trials running at Beaumont Hospital - Dearborn
Breast Cancer
Gastroesophageal Junction Adenocarcinoma
Esophageal Adenocarcinoma
Cancer
Esophageal Carcinoma
Lung Cancer
Non-Small Cell Lung Cancer
Ovarian Cancer
Bile Duct Cancer
Fallopian Tube Cancer
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Shorter Chemo-Immunotherapy Without Anthracyclines
for Breast Cancer
This phase III trial compares the effects of shorter chemotherapy (chemo)-immunotherapy without anthracyclines to usual chemo-immunotherapy for the treatment of early-stage triple negative breast cancer. Paclitaxel is in a class of medications called anti-microtubule agents. It stops cancer cells from growing and dividing and may kill them. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of cancer cells. Cyclophosphamide is in a class of medications called alkylating agents. It works by damaging the cell's deoxyribonucleic acid (DNA) and may kill cancer cells. It may also lower the body's immune response. Docetaxel is in a class of medications called taxanes. It stops cancer cells from growing and dividing and may kill them. Doxorubicin is an anthracycline chemotherapy drug that damages DNA and may kill cancer cells. Pembrolizumab may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Shorter treatment without anthracycline chemotherapy may work the same as the usual anthracycline chemotherapy treatment for early-stage triple negative breast cancer.
Recruiting2 awards Phase 347 criteria
Omitting Radiation Therapy
for Breast Cancer
The purpose of this study is to compare the effects on low risk breast cancer receiving usual care that includes regional radiation therapy, with receiving no regional radiation therapy. Researchers want to see if not giving this type of radiation treatment works as well at preventing breast cancer from coming back.
Recruiting2 awards Phase 319 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Beaumont Hospital - Dearborn?
Beaumont Hospital - Dearborn is a medical facility located in Dearborn, Michigan. This center is recognized for care of Cancer, Breast Cancer, Recurrence, Lung Cancer, Ovarian Cancer and other specialties. Beaumont Hospital - Dearborn is involved with conducting 237 clinical trials across 405 conditions. There are 24 research doctors associated with this hospital, such as Tareq Al Baghdadi, Laura K. Gowans, Philip J. Stella, and Samir Narayan.